Last week in Cuba was one of the three weeks with the highest number of COVID-19-positive cases diagnosed since the novel coronavirus first broke out on the island. This was informed on Monday by deputy prime minister, Roberto Morales Ojeda, during the meeting of the Temporary Working Group for the Prevention and Control of the epidemic.

Cuba broke a record in the number of PCR tests for one day with 20,578 samples analyzed in the country's laboratories, said today on Twitter the Cuban president, Miguel Diaz-Canel Bermudez.

Cuba studied 8,274 samples for COVID 19, resulting in 1,041 positive ones. The country accumulates 2,558,296 samples taken and 57,607 positive.

The Cuban COVID-19 candidate vaccine SOBERANA-02 started phase III clinical trials Monday in the capital Havana with a population segment between 19 to 64 years of age.

Despite tireless efforts to control the latest COVID-19 flare up in the capital Havana, its spread keeps hitting the city province with reports of 362 confirmed cases on Monday, a high figure according to the Provincial Defense Council.

HAVANA, Cuba, Mar 8 (ACN) Cuban minister of public health, Jose Angel Portal Miranda, said today that in the Cuban health system women represent more than 70 % of workers, and highlighted the commitment of women in the fight against the COVID-19 pandemic in the country.

Cuba studied 20,578 samples for COVID 19, resulting in 873 positive ones. The country accumulates 2,540,022 samples taken and 56,566 positive.

Dagmar Garcia Rivera, director of research at the Finlay Institute of Vaccines, reported today on Twitter that the weather conditions in Havana did not stop the beginning of phase 3 trials of the Cuban anti-COVID-19 vaccine candidate, Soberana 02, in the early hours of Monday morning in the capital.

Cuba has 22 molecular biology laboratories, of very expensive technology, in addition to the resources used, in which the positive cases to the COVID-19 are diagnosed, despite the blockade of the United States against the island for almost six decades ago and that every day is worsening.

Cuba studied for COVID-19 18,036 samples, resulting in 777 positive ones. The country accumulates 2,482,557 samples taken and 54, 085 positive.

Patients who are asymptomatic or have mild symptoms during the evolution of COVID-19 develop a lower immunity to the disease and, therefore, are more vulnerable to reinfection and to suffer from other conditions, said Dr. Francisco Duran, national director of Epidemiology of Cuban health ministry(MINSAP by its Spannish acronym), today in Havana.

HAVANA, Cuba, Mar 5 (ACN) A clinical trial in pediatric ages could begin in April, announced in the capital Dagmar Garcia Rivero, director of Research of the Finlay Vaccine Institute (IFV).

Havana, March 4 (ACN) Research studies by the Havana-based Hematology and Immunology Institute revealed that COVID-19 convalescents who were either asymptomatic or mild symptomatic may develop less immunity and be reinfected.

The Cuban COVID-19 candidate vaccine SOBERANA 02 entered phase III clinical trials in Havana to prove its efficacy.